Drug Profile
Ulinastatin - Techpool
Alternative Names: Techpool RoanLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Techpool Bio-Pharma
- Class Anti-inflammatories; Cytoprotectives; Furans; Glycoproteins; Uroprotectives
- Mechanism of Action Serine protease inhibitors; Trypsin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Pancreatitis; Vascular disorders
- No development reported Severe acute respiratory syndrome
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Severe acute respiratory syndrome(In volunteers) in China (IV, Injection)
- 08 Jun 2018 Chemical structure information added
- 12 Jan 2016 TechPool and Peking Union Medical College Hospital plans a phase IV trial for Sepsis and Septic shock in China (NCT02647554)